Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stock
Investor Presentation
Q3 FY26
Investor Presentation
Q1 FY26
Investor Presentation
Q4 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Discovery themes featuring this stock
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
163.30 | 1,969 Cr | -11.72 | 1.26 | 0.00 | -10.74 | -2.87 | -3.54 | ||
426.10 | 1,666 Cr | 25.29 | 3.15 | 0.26 | 12.47 | 17.32 | 12.06 | ||
121.10 | 1,599 Cr | -2160.82 | 0.00 | 0.00 | 9.60 | 103.10 | -7.07 | ||
430.00 | 1,315 Cr | 592.45 | 0.99 | 1.17 | 0.17 | 2.94 | 0.10 | ||
357.50 | 1,151 Cr | 22.90 | 2.98 | 11.15 | 11.09 | 14.48 | 12.41 | ||
107.00 | 1,146 Cr | 8.69 | 0.88 | 0.93 | 10.17 | 11.74 | 6.21 | ||
83.44 | 1,131 Cr | 13.59 | 0.68 | 1.44 | 6.01 | 8.39 | 4.01 | ||
| Median: 7 Co. | — | 163.30 | 1,315 Cr | 13.59 | 0.99 | 0.93 | 9.60 | 11.74 | 4.01 |
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Thirumalai Chemicals Ltd (TIRUMALCHM) is currently trading at 170.85 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Thirumalai Chemicals Ltd. is an integrated Indian specialty chemicals manufacturer producing phthalic anhydride, maleic anhydride, fumaric and malic acids, food-grade ingredients and downstream derivatives from manufacturing hubs in Ranipet, Dahej, Malaysia and a new greenfield facility in the USA, selling into plastics, resins, food, pharma and coatings markets across Europe, North America, Asia and Africa. The company has materially expanded capacity with a 40 KTPA Maleic Anhydride / food ingredients plant in West Virginia, USA; first commercial MAn sales began in December 2025, modular construction leveraged Indian fabrication, and management expects payback within seven years while completing commissioning and stabilization during H1 CY26. Financial performance weakened sharply in Q3 and 9M FY26: consolidated 9M loss widened to INR -140 crore with EBITDA margin compression and standalone PAT turned negative, driven by weak global demand, tariff-related disruptions, elevated distributor inventories and higher finance costs that pressured cashflows and margins during the period. TCL retains structural strengths: top-three global Phthalic Anhydride position, integrated feedstock-to-derivative manufacturing, extensive export mix (Europe 43%, North America 25%), robust R&D and certifications, and sustainability practices including ZLD, waste-heat recovery and renewable energy contributing meaningfully to operational resilience. Market headwinds include soft global chemical demand (utilization ~70–75%), aggressive low-cost competition from China/Korea, tariff disruptions affecting UPR and downstream customers, and near-term margin pressure; management is prioritizing process improvements, gas conversion, energy optimization and operational rationalization to restore profitability.
Over the past 52 weeks, Thirumalai Chemicals Ltd has traded between a low of ₹158.40 and a high of ₹328.70. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Thirumalai Chemicals Ltd has a market capitalization of approximately 1,968.63. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Thirumalai Chemicals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -11.72 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 1,968.63 Cr, Thirumalai Chemicals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Thirumalai Chemicals Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Thirumalai Chemicals Ltd is -11.72. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Thirumalai Chemicals Ltd. is an integrated Indian specialty chemicals manufacturer producing phthalic anhydride, maleic anhydride, fumaric and malic acids, food-grade ingredients and downstream derivatives from manufacturing hubs in Ranipet, Dahej, Malaysia and a new greenfield facility in the USA, selling into plastics, resins, food, pharma and coatings markets across Europe, North America, Asia and Africa.
The company has materially expanded capacity with a 40 KTPA Maleic Anhydride / food ingredients plant in West Virginia, USA; first commercial MAn sales began in December 2025, modular construction leveraged Indian fabrication, and management expects payback within seven years while completing commissioning and stabilization during H1 CY26.
Financial performance weakened sharply in Q3 and 9M FY26: consolidated 9M loss widened to INR -140 crore with EBITDA margin compression and standalone PAT turned negative, driven by weak global demand, tariff-related disruptions, elevated distributor inventories and higher finance costs that pressured cashflows and margins during the period.
TCL retains structural strengths: top-three global Phthalic Anhydride position, integrated feedstock-to-derivative manufacturing, extensive export mix (Europe 43%, North America 25%), robust R&D and certifications, and sustainability practices including ZLD, waste-heat recovery and renewable energy contributing meaningfully to operational resilience.
Market headwinds include soft global chemical demand (utilization ~70–75%), aggressive low-cost competition from China/Korea, tariff disruptions affecting UPR and downstream customers, and near-term margin pressure; management is prioritizing process improvements, gas conversion, energy optimization and operational rationalization to restore profitability.
Chemicals & Petrochemicals
Commodity Chemicals
1,969 Cr
High Risk
-11.7
42.3
—
1.3
328.70
158.40
Sales CAGR
Profit CAGR
ROE
ROCE
Bearish
4
Neutral
5
Bullish
5
Bearish
31
Neutral
5
Bullish
10
Bearish
27
Neutral
0
Bullish
5
